Internal Medicine, Infectious Disease · Nashville, TN
NPI
1770640187
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
316 22nd Ave N
Nashville, TN, 37203
Phone (615) 284-5185
Groups this clinician bills Medicare through
Medicare paid, 2024
$55K
768 services
Medicare patients, 2024
235
Average age 71
Drug cost, 2024
$3.0M
3,047 prescriptions
Company payments, 2025
$16.24
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark B Carr was code 99232 (hospital e&m - subsequent), 257 times for 107 patients. In total Mark B Carr billed 768 services in 14 codes, and Medicare paid $55K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-06-13.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 257 | 107 | $54.64 | $14K |
| 99214 Office E&M - Established | Office | 237 | 123 | $80.19 | $19K |
| 99233 Hospital E&M - Subsequent | Facility | 95 | 45 | $78.65 | $7,471 |
| 99222 Hospital E&M - Initial | Facility | 89 | 82 | $88.59 | $7,885 |
| 99215 Office E&M - Established | Office | 21 | 15 | $108.16 | $2,271 |
| 99223 Hospital E&M - Initial | Facility | 20 | 20 | $116.45 | $2,329 |
| G0008 Administration of influenza virus vaccine | Office | 11 | 11 | $29.78 | $328 |
| 90662 Vaccine Product | Office | 11 | 11 | $79.38 | $873 |
By year: 2022 $75K for 1,070 services; 2023 $71K for 954 services; 2024 $55K for 768 services.
Medicare prescription drug claims, 2024
In 2024, the drug Mark B Carr prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 273 prescriptions and refills. In total Mark B Carr wrote 3,047 Medicare prescriptions that cost $3.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 273 | 281 | 26 | $1.2M |
| Doxycycline Hyclate Generic | 213 | 307 | 46 | $4,820 |
| Cefadroxil Generic | 130 | 173 | 27 | $4,434 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 94 | 146 | 22 | $2,141 |
| Ceftriaxone Ceftriaxone Sodium | 91 | 91 | 22 | $8,659 |
| Descovy Emtricitabine/Tenofov Alafenam | 89 | 89 | Under 11 | $196K |
| Juluca Dolutegravir/Rilpivirine | 88 | 88 | Under 11 | $320K |
| Cefdinir Generic | 79 | 89 | 18 | $4,301 |
| Doxycycline Monohydrate Generic | 73 | 92 | 22 | $3,034 |
| Odefsey Emtricitab/Rilpiviri/Tenof Ala | 63 | 63 | Under 11 | $220K |
| Ciprofloxacin Hcl Generic | 62 | 74 | 18 | $928 |
| Atazanavir Sulfate Generic | 62 | 91 | Under 11 | $54K |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 60 | 70 | Under 11 | $288K |
| Fluconazole Generic | 60 | 80 | 17 | $1,776 |
| Levofloxacin Generic | 53 | 61 | 14 | $1,491 |
Brand drugs: - claims; generic drugs: 2,199 claims; opioid claims: 52.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark B Carr $16.24 ($16.24 in general payments such as food, travel and fees) from 1 company. The largest payer was Insmed, Inc. with $16.24.
| Company | Payments | Amount |
|---|---|---|
| Insmed, Inc. INSM | 1 | $16.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.